XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 71 filers reported holding XENON PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $253,000 | +29.7% | 16,451 | -6.7% | 0.02% | +30.8% |
| Q3 2020 | $195,000 | -47.6% | 17,633 | -40.6% | 0.01% | -48.0% |
| Q2 2020 | $372,000 | +48.8% | 29,679 | +34.4% | 0.02% | +25.0% |
| Q1 2020 | $250,000 | +17.9% | 22,089 | +37.4% | 0.02% | +122.2% |
| Q3 2018 | $212,000 | +29.3% | 16,074 | -9.9% | 0.01% | +50.0% |
| Q2 2018 | $164,000 | – | 17,837 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ghost Tree Capital, LLC | 850,000 | $15,215,000 | 3.58% |
| ACUTA CAPITAL PARTNERS, LLC | 412,500 | $7,384,000 | 2.66% |
| BVF INC/IL | 3,481,778 | $62,324,000 | 2.34% |
| Soleus Capital Management, L.P. | 708,117 | $12,675,000 | 2.28% |
| COMMODORE CAPITAL LP | 301,392 | $5,395,000 | 2.15% |
| DAFNA Capital Management LLC | 406,535 | $7,277,000 | 1.73% |
| Parkman Healthcare Partners LLC | 374,395 | $6,702,000 | 1.56% |
| Avoro Capital Advisors LLC | 3,650,000 | $65,335,000 | 1.13% |
| KNOTT DAVID M | 144,101 | $2,579,000 | 1.10% |
| Orbimed Advisors | 2,497,917 | $44,713,000 | 0.42% |